126 related articles for article (PubMed ID: 18709536)
21. Antifungal susceptibility testing of micafungin against Candida glabrata isolates.
Oliveira ER; Fothergill A; Kirkpatrick WR; Patterson TF; Redding SW
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Apr; 105(4):457-9. PubMed ID: 18329581
[TBL] [Abstract][Full Text] [Related]
22. Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy.
Chittick P; Palavecino EL; Delashmitt B; Evans J; Peacock JE
Antimicrob Agents Chemother; 2009 Dec; 53(12):5306-7. PubMed ID: 19738005
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of micafungin for treating febrile neutropenia in hematological malignancies.
Goto N; Hara T; Tsurumi H; Ogawa K; Kitagawa J; Kanemura N; Kasahara S; Yamada T; Shimizu M; Nakamura M; Matsuura K; Moriwaki H
Am J Hematol; 2010 Nov; 85(11):872-6. PubMed ID: 20882524
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.
Sohn HS; Lee TJ; Kim J; Kim D
Clin Ther; 2009 May; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111
[TBL] [Abstract][Full Text] [Related]
25. The echinocandins.
Cappelletty D; Eiselstein-McKitrick K
Pharmacotherapy; 2007 Mar; 27(3):369-88. PubMed ID: 17316149
[TBL] [Abstract][Full Text] [Related]
26. Invasive pulmonary aspergillosis and pulmonary cryptococcosis really coexist in immunocompromised host.
Lin CM; Tsai YH; Huang CC; Lee CH; Chiang PC; Huang SF; Liu HP
J Infect; 2006 Aug; 53(2):e55-8. PubMed ID: 16325257
[TBL] [Abstract][Full Text] [Related]
27. Micafungin.
Carver PL
Ann Pharmacother; 2004 Oct; 38(10):1707-21. PubMed ID: 15340133
[TBL] [Abstract][Full Text] [Related]
28. Disseminated cryptococcosis as a complication of lupus nephritis.
Beji S; Hajji M; El Kateb H; Kosai I; Jebali H; Kheder R; Fatma LB; Rais L; Laameri L; Krid M; Zouaghi K
Saudi J Kidney Dis Transpl; 2017; 28(6):1435-1439. PubMed ID: 29265061
[TBL] [Abstract][Full Text] [Related]
29. Clinical effects of micafungin, a novel echinocandin antifungal agent, on systemic fungal infections in surgery, emergency, and intensive-care medicine: evaluation using the AKOTT algorithm.
Aikawa N; Kusachi S; Oda S; Takesue Y; Tanaka H
J Infect Chemother; 2009 Aug; 15(4):219-27. PubMed ID: 19688240
[TBL] [Abstract][Full Text] [Related]
30. Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial.
Oyake T; Kowata S; Murai K; Ito S; Akagi T; Kubo K; Sawada K; Ishida Y
Eur J Haematol; 2016 Jun; 96(6):602-9. PubMed ID: 26216048
[TBL] [Abstract][Full Text] [Related]
31. Micafungin: a new echinocandin antifungal.
Joseph JM; Jain R; Danziger LH
Pharmacotherapy; 2007 Jan; 27(1):53-67. PubMed ID: 17192162
[TBL] [Abstract][Full Text] [Related]
32. Cryptococcal meningitis presenting concurrently with systemic lupus erythematosus.
Mok CC; Lau CS; Yuen KY
Clin Exp Rheumatol; 1998; 16(2):169-71. PubMed ID: 9536394
[TBL] [Abstract][Full Text] [Related]
33. Disseminated invasive aspergillosis successfully treated with micafungin in a renal transplant recipient.
Wadi J; Al-kawasmeh SI; Kamel MT; AlJayyousi BB
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):914-8. PubMed ID: 20814131
[TBL] [Abstract][Full Text] [Related]
34. A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients.
de Wet N; Llanos-Cuentas A; Suleiman J; Baraldi E; Krantz EF; Della Negra M; Diekmann-Berndt H
Clin Infect Dis; 2004 Sep; 39(6):842-9. PubMed ID: 15472817
[TBL] [Abstract][Full Text] [Related]
35. Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis.
Laverdière M; Lalonde RG; Baril JG; Sheppard DC; Park S; Perlin DS
J Antimicrob Chemother; 2006 Apr; 57(4):705-8. PubMed ID: 16464893
[TBL] [Abstract][Full Text] [Related]
36. Micafungin versus caspofungin in the treatment of Candida glabrata infection: a case report.
Yamada SM; Tomita Y; Yamaguchi T; Matsuki T
J Med Case Rep; 2016 Nov; 10(1):316. PubMed ID: 27821139
[TBL] [Abstract][Full Text] [Related]
37. A comparative analysis of micafungin and caspofungin for empirical antifungal therapy in antibiotic-unresponsive febrile patients with hematologic malignancies.
Seko T; Usami E; Kimura M; Nakao T; Matsuoka T; Yoshimura T; Kanamori N; Tachi T; Teramachi H
Pharmazie; 2016 Aug; 71(8):484-488. PubMed ID: 29442037
[TBL] [Abstract][Full Text] [Related]
38. Effective blood concentration of micafungin for pulmonary aspergillosis.
Shimoeda S; Ohta S; Kobayashi H; Yamato S; Sasaki M; Kawano K
Biol Pharm Bull; 2006 Sep; 29(9):1886-91. PubMed ID: 16946503
[TBL] [Abstract][Full Text] [Related]
39. Cryptococcal meningitis in Chinese patients with systemic lupus erythematosus.
Zhong Y; Li M; Liu J; Zhang W; Peng F
Clin Neurol Neurosurg; 2015 Apr; 131():59-63. PubMed ID: 25704191
[TBL] [Abstract][Full Text] [Related]
40. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
